Based in San Francisco, LUZ is a market leading life sciences translation provider, specializing in medical devices and regulatory activities. LUZ services a number of the world’s leading pharmaceutical and medical device manufacturers, enjoying a preferred supplier relationship with certain customers. The acquisition strengthens RWS’s leading position in global Life Sciences both in the US and Europe.

Walder Wyss acted as RWS' legal advisor on that transaction. The team was led by Robert von Rosen (Partner, Corporate M&A) and further included Alexander Gutmans (Partner, Corporate M&A), Michael Isler (Partner, IP/IT), David M. Hill (Associate, Employment) and Jonas Knechtli (Associate, Corporate/Commercial).